<DOC>
	<DOCNO>NCT02120339</DOCNO>
	<brief_summary>Estimate effect chronic beta-adrenergic receptor blockade carvedilol RV function patient PAH . Assess safety tolerability chronic carvedilol therapy patient PAH</brief_summary>
	<brief_title>Carvedilol PAH A Pilot Study Efficacy Safety</brief_title>
	<detailed_description>This prospective , open label , uncontrolled , pilot study examine safety efficacy beta-blocker therapy carvedilol RV function stable PAH Patients World Health Organization ( WHO ) functional class II III symptom RV ejection fraction ( EF ) &lt; 40 % . Twenty-five evaluable patient enrol University Minnesota . Specific Aims : 1.1 Primary Efficacy Endpoint : Adult male female stable dose approve PAH medication undergo cardiac magnetic resonance imaging ( MRI ) , right heart catheterization ( RHC ) , echocardiogram , 6-minute walk test ( 6-MWT ) , measurement plasma NT-ProBNP serum catecholamine , quality life assessment . Patients receive carvedilol ( 3.25 mg/kg bid escalate 25 mg/kg bid 3 month ) . Testing repeated end study ( month 6 ) . RVEF measure cardiac MRI primary efficacy endpoint . We define 5 % increase RVEF meaningful change .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Carvedilol</mesh_term>
	<criteria>1 . Subjects eligible participate study follow condition exist : 2 . Age &gt; 18 year 3. WHO category 1 pulmonary arterial hypertension ( Dana Point 2008 ) 4. WHO functional class IIIII 5 . RVEF cardiac MRI &lt; 40 % 6 . Mean pulmonary artery pressure &gt; 40 mm Hg 7 . Stable PAHspecific therapy define change PAHspecific treatment functional class past 3 month . Patient either mono combination PAHspecific therapy 1 . Subjects exclude participation study follow condition exist : 2 . Significant persistent bradycardia ( rest heart rate &lt; 60 bpm ) without permanent pacemaker 3 . Second third degree AV block without permanent pacemaker 4 . Significant sinus tachycardia ( rest heart rate &gt; 100 bpm ) 5 . Use antiarrhythmic drug 6 . Hypotension define systolic blood pressure &lt; 100 mmHg time enrollment 7 . Significant illness past 30 day require hospitalization 8 . Acute decompensated right heart failure within past 30 day 9 . Known allergy intolerance carvedilol Î² blockers 10 . Cardiac index &lt; 2 l/min/m2 right atrial pressure &gt; 15 mm Hg 11 . Asthma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Hypertension</keyword>
	<keyword>PAH</keyword>
</DOC>